<DOC>
	<DOCNO>NCT01196689</DOCNO>
	<brief_summary>The purpose study study pharmacokinetics adolescent .</brief_summary>
	<brief_title>Pharmacokinetics Adolescents</brief_title>
	<detailed_description>An open , single centre , phase I study male adolescent asthma , age 12 17 year , ass pharmacokinetics orally administer AZD1981 tablet 100 mg twice daily 61/2 day .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Provision inform consent prior study specific procedures A minimum 6 month document history asthma Be nonsmoker exsmoker stop smoke &gt; 6 month prior Visit 1 ( preentry ) Any clinically significant disease disorder , opinion investigator , may either put patient risk participation study , influence result study , patient 's ability participate Any clinically relevant abnormal finding phys.examination , clinical chemistry , haematology , urinalysis , vital sign , ECG baseline , opinion investigator , may put patient risk participation study</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Pharmacokinetics AZD1981</keyword>
	<keyword>Asthma</keyword>
</DOC>